In Silico Veritas: The pitfalls and challenges of predicting GPCR-ligand interactions

Pharmaceuticals

Volumn 4, Issue 9, 2011, Pages 1196-1215

  Roumen, Luc ^a   Sanders, Marijn P A ^b   Vroling, Bas ^b   de Esch, Iwan J P ^a   de Vlieg, Jacob ^b   Leurs, Rob ^a   Klomp, Jan P G ^c   Nabuurs, Sander B ^b   de Graaf, Chris ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MSD   (Netherlands)

Author keywords

Comparative modeling; G protein coupled receptor (GPCR); GPCR Dock 2010; Ligand binding mode prediction

Indexed keywords

CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR4; CYCLOPEPTIDE; DOPAMINE 3 RECEPTOR; ETICLOPRIDE; G PROTEIN COUPLED RECEPTOR;

ACCURACY; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; COMPUTER MODEL; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DNA TEMPLATE; LIGAND BINDING; MOLECULAR DOCKING; PREDICTION; PROTEIN INTERACTION; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 80053608032     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4091196     Document Type: Review

References (71)

1. de Graaf, C.; Rognan, D. Customizing G protein-coupled receptor models for structure-based virtual screening. Curr. Pharm. Des. 2009, 15, 4025-4048.
2. Eswar, N.; Sali, A.; John, B.T.; David, J.T. Comparative Modeling of Drug Target Proteins. In Comprehensive Medicinal Chemistry II; Elsevier: Oxford, UK, 2007; pp. 215-236.
3. Moult, J.; Pedersen, J.T.; Judson, R.; Fidelis, K. A large-scale experiment to assess protein structure prediction methods. Proteins 1995, 23, ii-v.
4. Janin, J. Welcome to CAPRI: A critical assessment of predicted interactions. Proteins 2002, 47, 257.
5. Moitessier, N.; Englebienne, P.; Lee, D.; Lawandi, J.; Corbeil, C.R. Towards the development of universal, fast and highly accurate docking/scoring methods: A long way to go. Br. J. Pharmacol. 2008, 153, S7-S26.
6. Kufareva, I.; Rueda, M.; Katritch, V.; Participants, G.; Stevens, R.C.; Abagyan, R. Status of GPCR modeling and docking as reflected by community wide GPCR DOCK 2010 assessment. Structure 2011, 19, 1108-1126.
7. Michino, M.; Abola, E.; participants, G.D.; Brooks, C.L.; Dixon, J.S.; Moult, J.; Stevens, R.C. Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008. Nat. Rev. Drug Discov. 2009, 8, 455-463.
8. Jaakola, V.-P.; Griffith, M.T.; Hanson, M.A.; Cherezov, V.; Chien, E.Y.T.; Lane, J.R.; Ijzerman, A.P.; Stevens, R.C. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008, 322, 1211-1217.
9. Chien, E.Y.T.; Liu, W.; Zhao, Q.; Katritch, V.; Won Han, G.; Hanson, M.A.; Shi, L.; Newman, A.H.; Javitch, J.A.; Cherezov, V.; et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010, 330, 1091-1095.
10. Wu, B.; Chien, E.Y.T.; Mol, C.D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F.C.; et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330, 1066-1071.
11. Cherezov, V.; Rosenbaum, D.M.; Hanson, M.A.; Rasmussen, S.G.; Thian, F.S.; Kobilka, T.S.; Choi, H.-J.; Kuhn, P.; Weis, W.I.; Kobilka, B.K.; et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318, 1258-1265.
12. Warne, T.; Serrano-Vega, M.J.; Baker, J.G.; Moukhametzianov, R.; Edwards, P.C.; Henderson, R.; Leslie, A.G.W.; Tate, C.G.; Schertler, G.F.X. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454, 486-491.
13. Gloriam, D.E.; Foord, S.M.; Blaney, F.E.; Garland, S.L. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J. Med. Chem. 2009, 52, 4429-4442.
14. Lundstrom, K.; Turpin, M.P.; Large, C.; Robertson, G.; Thomas, P.; Lewell, X.Q. Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in cho cells with the semliki forest virus system. J. Recept. Signal Trans. 1998, 18, 133-150.
15. Sartania, N.; Strange, P.G. Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors. J. Neurochem. 1999, 72, 2621-2624.
16. Shi, L.; Javitch, J.A. The binding site of aminergic G protein-coupled receptors: The transmembrane segments and second extracellular loop. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 437-467.
17. Thoma, G.; Streiff, M.B.; Kovarik, J.; Glickman, F.; Wagner, T.; Beerli, C.; Zerwes, H.-G. Orally bioavailable isothioureas block function of the chemokine receptor cxcr4 in vitro and in vivo. J. Med. Chem. 2008, 51, 7915-7920.
18. Rosenkilde, M.M.; Gerlach, L.-O.; Hatse, S.; Skerlj, R.T.; Schols, D.; Bridger, G.J.; Schwartz, T.W. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor. J. Biol. Chem. 2007, 282, 27354-27365.
19. Rosenkilde, M.M.; Gerlach, L.-O.; Jakobsen, J.S.; Skerlj, R.T.; Bridger, G.J.; Schwartz, T.W. Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor. J. Biol. Chem. 2004, 279, 3033-3041.
20. Wong, R.S.Y.; Bodart, V.; Metz, M.; Labrecque, J.; Bridger, G.; Fricker, S.P. Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors. Mol. Pharmacol. 2008, 74, 1485-1495.
21. DeMarco, S.J.; Henze, H.; Lederer, A.; Moehle, K.; Mukherjee, R.; Romagnoli, B.; Robinson, J.A.; Brianza, F.; Gombert, F.O.; Lociuro, S.; et al. Discovery of novel, highly potent and selective [beta]-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles. Bioorg. Med. Chem. 2006, 14, 8396-8404.
22. Moncunill, G.; Armand-Ugon, M.; Clotet-Codina, I.; Pauls, E.; Ballana, E.; Llano, A.; Romagnoli, B.; Vrijbloed, J.W.; Gombert, F.O.; Clotet, B.; et al. Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026. Mol. Pharmacol. 2008, 73, 1264-1273.
23. Ballesteros, J.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations of G protein-coupled receptors. Methods Neurosci. 1995, 25, 366-428.
24. Surgand, J.-S.; Rodrigo, J.; Kellenberger, E.; Rognan, D. A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 2006, 62, 509-538.
25. Vroling, B.; Sanders, M.; Baakman, C.; Borrmann, A.; Verhoeven, S.; Klomp, J.; Oliveira, L.; de Vlieg, J.; Vriend, G. GPCRDB: Information system for G protein-coupled receptors. Nucleic Acids Res. 2011, 39, D309-D319.
26. Sanders, M.P.; Fleuren, W.W.; Verhoeven, S.; van den Beld, S.; Alkema, W.; Klomp, J.P.; de Vlieg, J. ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs. BMC Bioinform. 2011, 12, 332.
27. Consortium, T.U. The universal protein resource (UniProt) in 2010. Nucleic Acids Res. 2010, 38, D142-D148.
28. Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R.; et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23, 2947-2948.
29. Scheerer, P.; Park, J.H.; Hildebrand, P.W.; Kim, Y.J.; Krausz, N.; Choe, H.-W.; Hofmann, K.P.; Ernst, O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455, 497-502.
30. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Trong, I.L.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
31. Xu, F.; Wu, H.; Katritch, V.; Han, G.W.; Jacobson, K.A.; Gao, Z.-G.; Cherezov, V.; Stevens, R.C. Structure of an agonist-bound human A2A adenosine receptor. Science 2011, 332, 322-327.
32. Rasmussen, S.G.F.; Choi, H.-J.; Fung, J.J.; Pardon, E.; Casarosa, P.; Chae, P.S.; DeVree, B.T.; Rosenbaum, D.M.; Thian, F.S.; Kobilka, T.S.; et al. Structure of a nanobody-stabilized active state of the beta2 adrenoceptor. Nature 2011, 469, 175-180.
33. Rasmussen, S.G.F.; DeVree, B.T.; Zou, Y.; Kruse, A.C.; Chung, K.Y.; Kobilka, T.S.; Thian, F.S.; Chae, P.S.; Pardon, E.; Calinski, D.; et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011, doi:10.1038/nature10361.
34. Deupi, X.; Dolker, N.; Lopez-Rodriguez, M.L.; Campillo, M.; Ballesteros, J.A.; Pardo, L. Structural models of class a G protein-coupled receptors as a tool for drug design: Insights on transmembrane bundle plasticity. Curr. Top. Med. Chem. 2007, 7, 991-998.
35. Deupi, X.; Olivella, M.; Govaerts, C.; Ballesteros, J.A.; Campillo, M.; Pardo, L. Ser and Thr residues modulate the conformation of pro-kinked transmembrane α-helices. Biophys. J. 2004, 86, 105-115.
36. de Graaf, C.; Foata, N.; Engkvist, O.; Rognan, D. Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening. Proteins 2008, 71, 599-620.
37. Goldfeld, D.A.; Zhu, K.; Beuming, T.; Friesner, R.A. Successful prediction of the intra-and extracellular loops of four G-protein-coupled receptors. Proc. Natl. Acad. Sci. USA 2011, 108, 8275-8280.
38. Mehler, E.L.; Hassan, S.A.; Kortagere, S.; Weinstein, H. Ab initio computational modeling of loops in G-protein-coupled receptors: Lessons from the crystal structure of rhodopsin. Proteins 2006, 64, 673-690.
39. Nikiforovich, G.V.; Taylor, C.M.; Marshall, G.R.; Baranski, T.J. Modeling the possible conformations of the extracellular loops in G-protein-coupled receptors. Proteins 2010, 78, 271-285.
40. MOE (The Molecular Operating Environment), Version 2009.10; Chemical Computing Group Inc. (http://www.chemcomp.com/): Montreal, Canada.
41. Berkhout, T.A.; Blaney, F.E.; Bridges, A.M.; Cooper, D.G.; Forbes, I.T.; Gribble, A.D.; Groot, P.H.E.; Hardy, A.; Ife, R.J.; Kaur, R.; et al. CCR2: Characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach. J. Med. Chem. 2003, 46, 4070-4086.
42. Jensen, P.C.; Nygaard, R.; Thiele, S.; Elder, A.; Zhu, G.; Kolbeck, R.; Ghosh, S.; Schwartz, T.W.; Rosenkilde, M.M. Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8. Mol. Pharmacol. 2007, 72, 327-340.
43. Rosenkilde, M.M.; Andersen, M.B.; Nygaard, R.; Frimurer, T.M.; Schwartz, T.W. Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III,-IV, and-VI. Mol. Pharmacol. 2007, 71, 930-941.
44. Govaerts, C.; Blanpain, C.; Deupi, X.; Ballet, S.; Ballesteros, J.A.; Wodak, S.J.; Vassart, G.; Pardo, L.; Parmentier, M. The TXP motif in the second transmembrane helix of CCR5. J. Biol. Chem. 2001, 276, 13217-13225.
45. AMBER 11. Case, D.A.; Darden, T.A.; Cheatham T.E., III; Simmerling, C.L.; Wang, J.; Duke, R.E.; Luo, R.; Walker, R.C.; Zhang, W.; Merz, K.M.; et al. University of California, San Francisco, USA, 2010.
46. Lovell, S.C.; Davis, I.W.; Arendall, W.B.; de Bakker, P.I.W.; Word, J.M.; Prisant, M.G.; Richardson, J.S.; Richardson, D.C. Structure validation by Cα geometry: φ{symbol}, ψ and Cβ deviation. Proteins 2003, 50, 437-450.
47. Dunbrack, R.L.; Cohen, F.E. Bayesian statistical analysis of protein side-chain rotamer preferences. Protein Sci. 1997, 6, 1661-1681.
48. Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The protein data bank. Nucleic Acids Res. 2000, 28, 235-242.
49. Krieger, E.; Joo, K.; Lee, J.; Lee, J.; Raman, S.; Thompson, J.; Tyka, M.; Baker, D.; Karplus, K. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins 2009, 77, 114-122.
50. Canutescu, A.A.; Shelenkov, A.A.; Dunbrack, R.L. A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci. 2003, 12, 2001-2014.
51. Hooft, R.W.W.; Vriend, G.; Sander, C.; Abola, E.E. Errors in protein structures. Nature 1996, 381, 272.
52. Eswar, N.; Webb, B.; Marti-Renom, M.A.; Madhusudhan, M.S.; Eramian, D.; Shen, M.-Y.; Pieper, U.; Sali, A. Comparative Protein Structure Modeling Using Modeller. In Current Protocols in Bioinformatics; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2002.
53. Veldkamp, C.T.; Seibert, C.; Peterson, F.C.; de la Cruz, N.B.; Haugner, J.C., III; Basnet, H.; Sakmar, T.P.; Volkman, B.F. Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci. Signal. 2008, 1, ra4.
54. Kristiansen, K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: Molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol. Ther. 2004, 103, 21-80.
55. Ye, S.; Zaitseva, E.; Caltabiano, G.; Schertler, G.F.X.; Sakmar, T.P.; Deupi, X.; Vogel, R. Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature 2010, 464, 1386-1389.
56. Bokoch, M.P.; Zou, Y.; Rasmussen, S.G.F.; Liu, C.W.; Nygaard, R.; Rosenbaum, D.M.; Fung, J.J.; Choi, H.-J.; Thian, F.S.; Kobilka, T.S.; et al. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature 2010, 463, 108-112.
57. Huber, T.; Sakmar, T.P. Escaping the flatlands: New approaches for studying the dynamic assembly and activation of GPCR signaling complexes. Trends Pharmacol. Sci. 2011, 32, 410-419.
58. Ballesteros, J.A.; Shi, L.; Javitch, J.A. Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 2001, 60, 1-19.
59. Torrice, M.M.; Bower, K.S.; Lester, H.A.; Dougherty, D.A. Probing the role of the cation-pi interaction in the binding sites of GPCRs using unnatural amino acids. Proc. Natl. Acad. Sci. USA 2009, 106, 11919-11924.
60. Varady, J.; Wu, X.; Fang, X.; Min, J.; Hu, Z.; Levant, B.; Wang, S. Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: Discovery of novel and potent D3 ligands through a hybrid pharmacophore-and structure-based database searching approach. J. Med. Chem. 2003, 46, 4377-4392.
61. Sanders, M.P.A.; Verhoeven, S.; de Graaf, C.; Roumen, L.; de Vlieg, J.; Klomp, J.P.G. Snooker: A structure-based pharmacophore generation tool applied to class A GPCRs. J. Chem. Inf. Model. 2011, doi:10.1021/ci200088d.
62. Warr, W. ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). J. Comput. Aided Mol. Des. 2009, 23, 195-198.
63. Liu, X.; Bai, F.; Ouyang, S.; Wang, X.; Li, H.; Jiang, H. Cyndi: A multi-objective evolution algorithm based method for bioactive molecular conformational generation. BMC Bioinformat. 2009, 10, 101.
64. Nabuurs, S.B.; Wagener, M.; de Vlieg, J. A flexible approach to induced fit docking. J. Med. Chem. 2007, 50, 6507-6518.
65. Verdonk, M.L.; Cole, J.C.; Hartshorn, M.J.; Murray, C.W.; Taylor, R.D. Improved protein-ligand docking using GOLD. Proteins 2003, 52, 609-623.
66. Angel, T.E.; Chance, M.R.; Palczewski, K. Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 2009, 106, 8555-8560.
67. Pardo, L.; Deupi, X.; Dölker, N.; López-Rodríguez, M.L.; Campillo, M. The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. Chembiochem 2007, 8, 19-24.
68. Katritch, V.; Jaakola, V.-P.; Lane, J.R.; Lin, J.; Ijzerman, A.P.; Yeager, M.; Kufareva, I.; Stevens, R.C.; Abagyan, R. Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists. J. Med. Chem. 2010, 53, 1799-1809.
69. Roberts, B.C.; Mancera, R.L. Ligand-protein docking with water molecules. J. Chem. Inf. Model. 2008, 48, 397-408.
70. Verdonk, M.L.; Chessari, G.; Cole, J.C.; Hartshorn, M.J.; Murray, C.W.; Nissink, J.W.M.; Taylor, R.D.; Taylor, R. Modeling water molecules in protein-ligand docking using GOLD. J. Med. Chem. 2005, 48, 6504-6515.
71. Shimamura, T.; Shiroishi, M.; Weyand, S.; Tsujimoto, H.; Winter, G.; Katritch, V.; Abagyan, R.; Cherezov, V.; Liu, W.; Han, G.W.; et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011, 475, 65-70.